Related Experiment Video
Updated: Jan 8, 2026

A High-Throughput Luciferase Assay to Evaluate Proteolysis of the Single-Turnover Protease PCSK9
Published on: August 28, 2018
Discovery of undescribed PCSK9 inhibitory activities in Annonaceous acetogenins from Polyalthia evecta
Chae-Yeong An1, Chan-Woong Park1, Pisey Pel1
1Natural Product Research Institute and Research Institute of Pharmaceutical Sciences, College of Pharmacy, Seoul National University, Seoul, 08826, Republic of Korea.
Abstract:
Bioassay-guided isolation using a HepG2 cell-based proprotein convertase subtilisin/kexin type 9 (PCSK9) ELISA led to the isolation of four previously unreported (1-4) and six known (5-10) mono-tetrahydrofuran Annonaceous acetogenins from the branches of Polyalthia evecta. The structures of all isolates were elucidated based on spectroscopic data analyses or chemical reaction including 1D and 2D NMR, HRESIMS, LC-MS/MS of the lithium adducts, ECD measurements and the modified Mosher's method. All isolates were evaluated for their PCSK9 secretion inhibitory activities, and a plausible structure-activity relationship was proposed. Among them, compound 5 (annonacin) significantly suppressed PCSK9 secretion as well as expressions of PCSK9 mRNA and protein. Moreover, this compound 5 enhanced LDL uptake, and mitigated atorvastatin-induced upregulation of PCSK9. This study represents the first investigation for the PCSK9 inhibitory potential of acetogenin-class compounds.
More Related Videos
Related Concept Videos
Indirect-Acting Cholinergic Agonists: Mechanism of Action
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
GPCRs Regulate Adenylyl Cylase Activity

